Nature: Silicon highlights remaining questions over anthrax investigation
Nature discusses weaponization and silicon, but not much new yet.
Although no significant improvements in drug safety occurred while he was FDA Commissioner from 2002 to 2004, Dr. McClellan now acknowledges the need for improved safety surveillance at FDA, in a commentary in the April 26, 2007 New England Journal of Medicine. This issue contains several articles on FDA assessment of drug safety. Jerry Avorn,…
It is all too easy to find mistakes, misstatements and omissions made by public health officials around the Coronavirus pandemic. Consider the fluent but facile Dr. Fauci. Have you ever heard him say that the institute he directs has spent hundreds of millions of dollars on coronavirus research? Has he tried to help Americans understand any…
Fun news from Medpage Today: As of Monday at 8 a.m. EST, the unofficial U.S. COVID toll is 50,846,841 cases and 806,438 deaths, increases of 925,419 cases and 9,090 deaths versus a week ago. President Biden will address the nation on Tuesday night about the Omicron variant. (CNBC) Despite receiving boosters, Senators Elizabeth Warren (D.-Mass.) and Cory Booker (D-N.J.), and…
This graph comes from the Washington Post. Before 1993 there were many US measles cases, mainly due to waning of vaccine-induced immunity. Then an additional MMR dose was added to the vaccine schedule in the US, and measles immunity improved. There is no endemic measles in the US, helped by the fact there is no…
Soldiers from every other country that used anthrax vaccine have had medical problems, although information is limited Meryl Nass, MD May 26, 2007 Israel Dozens of Israeli soldiers who volunteered to take part in classified anthrax vaccine experiments years ago are reportedly still ill as a result, according to Israeli media. Here’s the article: United…
The first legal cases (outside the secret FISA court and post Snowden) questioning the legality of NSA spying come to the forefront next week. See the US News piece here. The first case seeks a broad preliminary injection against “some NSA surveillance programs” and will be heard Monday, Nov 18. It is a class action…
Comments are closed.
“But Jacobsen and others say the fact that the FBI has apparently failed to produce a powder to match the attack material suggests it must be very difficult to make.”
Or that the FBI is really incompetent. Which judging from their performance in the investigation seems to be the more likely hypothesis.